Entero Therapeutics, Inc. (ENTO) — Financial Flexibility Index
Entero Therapeutics, Inc. (ENTO) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of $-855.69K (operating CF $-855.69K minus capex $0.00) represents 0% of total liabilities ($45.81 Million). Check ENTO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Entero Therapeutics, Inc. Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Entero Therapeutics, Inc. across 12 annual periods. For the full cash flow conversion analysis, see ENTO cash flow conversion.
Annual Financial Flexibility Index for Entero Therapeutics, Inc. (2013–2024)
Year-by-year free cash flow to debt coverage for Entero Therapeutics, Inc.. Explore ENTO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.33x | $-9.22 Million | $-9.22 Million | $27.61 Million | ▲ +90.8% |
| 2023 | -3.62x | $-11.88 Million | $-12.38 Million | $3.28 Million | ▲ +56.3% |
| 2022 | -8.28x | $-22.34 Million | $-22.34 Million | $2.70 Million | ▼ -639.4% |
| 2021 | -1.12x | $-21.97 Million | $-32.29 Million | $19.61 Million | ▼ -55.4% |
| 2020 | -0.72x | $-11.22 Million | $-11.22 Million | $15.56 Million | ▼ -30788.6% |
| 2019 | 0.00x | $10.06K | $-14.03K | $4.29 Million | ▲ +100.1% |
| 2018 | -3.53x | $-10.56 Million | $-10.87 Million | $3.00 Million | ▼ -88.3% |
| 2017 | -1.87x | $-7.15 Million | $-7.18 Million | $3.82 Million | ▼ -46.6% |
| 2016 | -1.28x | $-4.52 Million | $-4.53 Million | $3.54 Million | ▼ -317695.5% |
| 2015 | 0.00x | $-4.15K | $-4.17K | $10.32 Million | ▼ -92.3% |
| 2014 | 0.00x | $-821.39 | $-1.01K | $3.93 Million | ▼ -100.3% |
| 2013 | 0.06x | $56.55 | $56.55 | $939.30 | — |